MedPath

Training therapists to coach individuals with a neurological condition to use the SMART Arm.

Phase 3
Withdrawn
Conditions
Stroke
Neurological conditions
Stroke - Ischaemic
Stroke - Haemorrhagic
Neurological - Other neurological disorders
Registration Number
ACTRN12616000447459
Lead Sponsor
James Cook University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
All
Target Recruitment
50
Inclusion Criteria

1) Individuals with a neurological condition
Inclusion: Individuals with a neurological condition aged over 15 years whose arm function has been reduced as a result of the neurological condition, and that receive a service from Community Rehab nQ during the study period.

2) Occupational therapists, physiotherapists and rehabilitation assistants working at CRnQ who have participated in basic SMART Arm training as a minimum.

Exclusion Criteria

Individuals with a neurological condition who are unable to 'actively participate' in SMART Arm training. For example people with cognitive-linguistic impairments that limit their ability to understand and follow instructions sufficiently to enable participation.

Occupational Therapists, Physiotherapists and Rehab Assistants who have not received the basic SMART Arm training will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Strengths and weaknesses of current SMART Arm coaching will be assessed concurrently. This outcome will be assessed via a survey questionnaire designed specifically for this study. <br>All participating individuals will complete the survey questionnaire. A selection of participating individuals with a neurological condition and a selection of clinicians will be invited to participate in individual or focus group interviews to verify and explain the survey findings. [3 months after commencement of the trial]
Secondary Outcome Measures
NameTimeMethod
Therapists capability to coach individuals with a neurological condition to use the SMART Arm. This will be assessed using a capability assessment tool designed specifically for this study by participating individuals with a neurological condition and via self-report by participating clinicians. [6 months after commencement of the trial. ]
© Copyright 2025. All Rights Reserved by MedPath